Pre-transplant soluble CD30 level as a predictor of not only acute rejection and graft loss but pneumonia in renal transplant recipients

Transplant Immunology

Volumn 22, Issue 3-4, 2010, Pages 115-120

  Wang, Dong ^a   Wu, Wei Zhen ^a   Chen, Jin Hua ^a   Yang, Shun Liang ^a   Wang, Qing Hua ^a   Zeng, Zhang Xin ^a   Tan, Jian Ming ^a  

^a FUZHOU GENERAL HOSPITAL   (China)

Author keywords

Acute rejection; Pneumonia; Renal transplantation; SCD30

Indexed keywords

CD30 ANTIGEN;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY GRAFT; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PNEUMONIA; PREDICTION; PRIORITY JOURNAL; REFERENCE VALUE; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT FAILURE;

ADULT; ANTIGENS, CD30; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PNEUMONIA; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 77951631264     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2009.12.004     Document Type: Article

References (24)

1. Pascual M., Theruvath T., Kawai T., Tolkoff-Rubin N., Cosimi A.B. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002, 34(8):580-590.
2. McLaren A.J., Fuggle S.V., Welsh K.I., Gray D.W., Morris P.J Chronic allograft failure in human renal transplantation: a multivariate risk factor analysis. Ann Surg 2000, 232(1):98-103.
3. El-Agroudy A.E., Bakr MA, Shehab El-Dein A.B., Ghoneim M.A. Death with functioning graft in living donor kidney transplantation: analysis of risk factors. Am J Nephrol 2003, 23(3):186-193.
4. Smith C.A., Gruss H.J., Davis T., Anderson D., Farrah T., Baker E., et al. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 1993, 73(7):1349-1360.
5. Tarkowski M. Expression and a role of CD30 in regulation of T-cell activity. Curr Opin Hematol 2003, 10(4):267-271.
6. Pellegrini P., Berghella A.M., Contasta I., Adorno D. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response. Transpl Immunol 2003, 12(1):49-61.
7. Susal C., Pelzl S., Dohler B., Opelz G. Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30. J Am Soc Nephrol 2002, 13(6):1650-1656.
8. Wang D., Wu G.J., Wu W.Z., Yang S.L., Chen J.H., Wang H., et al. Pre- and post-transplant monitoring of soluble CD30 levels as predictor of acute renal allograft rejection. Transpl Immunol 2007, 17(4):278-282.
9. Wang D., Yang S.L., Wu W.Z., Wang Q.H., Zeng Z.X., Tan J.M., et al. Prediction of acute renal allograft rejection in early post-transplantation period by soluble CD30. Transpl Immunol 2006, 16(1):41-45.
10. Nikaein A., Spiridon C., Hunt J., Rosenthal J., Anderson A., Eichhorn E., et al. Pre-transplant level of soluble CD30 is associated with infection after heart transplantation. Clin Transplant 2007, 21(6):744-747.
11. Racusen L.C., Solez K., Colvin R.B., Bonsib S.M., Castro M.C., Cavallo T., et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999, 55(2):713-723.
12. Rajakariar R., Jivanji N., Varagunam M., Rafiq M., Gupta A., et al. High pre-transplant soluble CD30 levels are predictive of the grade of rejection. Am J Transplant 2005, 5(8):1922-1925.
13. Frezzolini A., Paradisi M., Ruffelli M., Cadoni S., De Pità O. Soluble CD30 in pediatric patients with atopic dermatitis. Allergy 1997, 52(1):106-109.
14. Romagnani S., Del Prete G., Maggi E., Chilosi M., Caligaris-Cappio F., Pizzolo G. CD30 and type 2T helper (Th2) responses. J Leukoc Biol 1995, 57(5):726-730.
15. Weimer R., Süsal C., Yildiz S., Staak A., Pelzl S., Renner F., et al. Post-transplant sCD30 and neopterin as predictors of chronic allograft nephropathy: impact of different immunosuppressive regimens. Am J Transplant 2006, 6(8):1865-1874.
16. Langan L.L., Park L.P., Hughes T.L., Irish A., Luxton G., Witt C.S., et al. Post-transplant HLA class II antibodies and high soluble CD30 levels are independently associated with poor kidney graft survival. Am J Transplant 2007, 7(4):847-856.
17. Bochner B.S., Klunk D.A., Sterbinsky S.A., Coffman R.L., Schleimer R.P. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 1995, 154(2):799-803.
18. Lukacs N.W., Tekkanat K.K., Berlin A., Hogaboam C.M., Miller A., Evanoff H., et al. Respiratory syncytial virus predisposes mice to augmented allergic airway responses via IL-13-mediated mechanisms. J Immunol 2001, 167(2):1060-1065.
19. Zhu Z., Ma B., Zheng T., Homer R.J., Lee C.G., Charo I.F., et al. IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling. J Immunol 2002, 168(6):2953-2962.
20. Akbari O., Stock P., Meyer E., Kronenberg M., Sidobre S., Nakayama T., et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003, 9(5):582-588.
21. Meier-Kriesche H.-U., Arndorfer J.A., Kaplan B. Association of antibody induction with short- and long-term cause-specific mortality in renal transplant recipients. J Am Soc Nephrol 2002, 13:769-772.
22. Ducloux D., Kazory A., Challier B., Coutet J., Bresson-Vautrin C., Motte G., et al. Long-term toxicity of antithymocyte globulin induction may vary with choice of agent: a single-center retrospective study. Transplantation 2004, 77:1029-1033.
23. Opelz G., Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 2004, 4(2):222-230.
24. Yang S.L., Wang D., Wu W.Z., Lin W.H., Xu T.Z., Cai J.Q., et al. Comparison of single bolus ATG and Basiliximab as induction therapy in presensitized renal allograft recipients receiving tacrolimus-based immunosuppressive regimen. Transpl Immunol 2008, 18(3):281-285.